Literature DB >> 31301327

Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.

Elyssa B Margolis1, Anushree N Karkhanis2.   

Abstract

Neural circuits that enable an organism to protect itself by promoting escape from immediate threat and avoidance of future injury are conceptualized to carry an "aversive" signal. One of the key molecular elements of these circuits is the kappa opioid receptor (KOR) and its endogenous peptide agonist, dynorphin. In many cases, the aversive response to an experimental manipulation can be eliminated by selective blockade of KOR function, indicating its necessity in transmitting this signal. The dopamine system, through its contributions to reinforcement learning, is also involved in processing of aversive stimuli, and KOR control of dopamine in the context of aversive behavioral states has been intensely studied. In this review, we have discussed the multiple ways in which the KORs regulate dopamine dynamics with a central focus on dopamine neurons and projections from the ventral tegmental area. At the neuronal level, KOR agonists inhibit dopamine neurons both in the somatodendritic region as well as at terminal release sites, through various signaling pathways and ion channels, and these effects are specific to different synaptic sites. While the dominant hypotheses are that aversive states are driven by decreases in dopamine and increases in dynorphin, reported exceptions to these patterns indicate these ideas require refinement. This is critical given that KOR is being considered as a target for development of new therapeutics for anxiety, depression, pain, and other psychiatric disorders.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31301327      PMCID: PMC6702044          DOI: 10.1016/j.neuint.2019.104504

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  158 in total

1.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Antonello Bonci; Howard L Fields
Journal:  J Neurophysiol       Date:  2004-12-22       Impact factor: 2.714

Review 3.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

4.  The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores.

Authors:  A Mansour; M T Hoversten; L P Taylor; S J Watson; H Akil
Journal:  Brain Res       Date:  1995-11-27       Impact factor: 3.252

5.  Kappa-opioids produce significantly greater analgesia in women than in men.

Authors:  R W Gear; C Miaskowski; N C Gordon; S M Paul; P H Heller; J D Levine
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

6.  Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling.

Authors:  Chia Li; Kristen E Pleil; Alice M Stamatakis; Steven Busan; Linh Vong; Bradford B Lowell; Garret D Stuber; Thomas L Kash
Journal:  Biol Psychiatry       Date:  2012-01-05       Impact factor: 13.382

7.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Authors:  Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

8.  Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.

Authors:  T S Shippenberg; R Bals-Kubik; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

9.  Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex.

Authors:  Elyssa B Margolis; Hagar Lock; Vladimir I Chefer; Toni S Shippenberg; Gregory O Hjelmstad; Howard L Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.

Authors:  Julia C Lemos; Clarisse A Roth; Daniel I Messinger; Harminder K Gill; Paul E M Phillips; Charles Chavkin
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

View more
  10 in total

Review 1.  Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.

Authors:  Claire Leconte; Raymond Mongeau; Florence Noble
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

2.  KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.

Authors:  Paige M Estave; Mary B Spodnick; Anushree N Karkhanis
Journal:  Handb Exp Pharmacol       Date:  2022

3.  Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

Authors:  Catherine M Cahill; Lindsay Lueptow; Hannah Kim; Raj Shusharla; Amy Bishop; Christopher J Evans
Journal:  Handb Exp Pharmacol       Date:  2022

4.  Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.

Authors:  Douglas Funk; Kathleen Coen; Sahar Tamadon; A D Lê
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

5.  Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula.

Authors:  Sarah C Simmons; Ryan D Shepard; Shawn Gouty; Ludovic D Langlois; William J Flerlage; Brian M Cox; Fereshteh S Nugent
Journal:  Neurobiol Stress       Date:  2020-11-17

6.  A projection from the paraventricular nucleus of the thalamus to the shell of the nucleus accumbens contributes to footshock stress-induced social avoidance.

Authors:  Xinwen Dong; Sa Li; Gilbert J Kirouac
Journal:  Neurobiol Stress       Date:  2020-10-31

Review 7.  Current Understanding of the Neural Circuitry in the Comorbidity of Chronic Pain and Anxiety.

Authors:  Teng Chen; Jing Wang; Yan-Qing Wang; Yu-Xia Chu
Journal:  Neural Plast       Date:  2022-02-15       Impact factor: 3.599

Review 8.  Neurobiology of Loneliness, Isolation, and Loss: Integrating Human and Animal Perspectives.

Authors:  Erika M Vitale; Adam S Smith
Journal:  Front Behav Neurosci       Date:  2022-04-08       Impact factor: 3.617

9.  Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.

Authors:  Antony D Abraham; Sanne M Casello; Benjamin B Land; Charles Chavkin
Journal:  Addict Neurosci       Date:  2022-01-25

10.  Brain opioid segments and striatal patterns of dopamine release induced by naloxone and morphine.

Authors:  Ehsan Shokri-Kojori; Mika Naganawa; Vijay A Ramchandani; Dean F Wong; Gene-Jack Wang; Nora D Volkow
Journal:  Hum Brain Mapp       Date:  2021-12-07       Impact factor: 5.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.